Several evidence-based strategies can help minimize vomiting and improve tolerability for patients taking semaglutide
doi: 10.1136/emj.20.6.560 [PubMed] 17766009 Sirianni AJ, Osterhoudt KC, Calello DP, Muller AA, Waterhouse MR, Goodkin MB, Weinberg GL, Henretig FM
View image online ( Patient holding injectable A new study uncovered an association between glucagon-like peptide-1 receptor agonist (GLP-1RAs) use and an increased risk of gastroparesis (GP) among patients with Type 2 diabetes
Conclusion GSH is synthesized from three precursor molecules, glutamate, cysteine, and glycine, through a two-step enzymatic reaction of GCLC and GS
Patients are more likely to choose drugs with lower cost sharing (in consultation with their physicians when all else is equal or similar between drugs), so the manufacturer has an incentive to provide a higher rebate to ensure that its drug has the lowest cost sharing among competitors and is thus more attractive to the patient